0399.HK - Innovative Pharmaceutical Biotech Limited

HKSE - HKSE Delayed Price. Currency in HKD
0.435
0.000 (0.00%)
As of 11:37AM HKT. Market open.
Stock chart is not supported by your current browser
Previous Close0.435
Open0.430
Bid0.425 x 0
Ask0.435 x 0
Day's Range0.430 - 0.435
52 Week Range0.405 - 0.640
Volume10,000
Avg. Volume575,023
Market Cap636.923M
Beta0.46
PE Ratio (TTM)N/A
EPS (TTM)-0.158
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuterslast month

    Singapore's Temasek sees deals slowing as trade tensions bite

    Singapore state investor Temasek Holdings cautioned it was looking to temper its pace of investments this year as trade tensions between world's top two economies ratchet up, after reporting a record high annual portfolio value. The cautious outlook underlines the challenges that state investment firms like Temasek face as rising protectionist policies and anti-globalization sentiments put their investment and risk management capabilities to test.

  • Reuterslast month

    Singapore's Temasek sees deals slowing as trade tensions bite

    Singapore state investor Temasek Holdings cautioned it was looking to temper its pace of investments this year as trade tensions between world's top two economies ratchet up, after reporting a record high annual portfolio value. The cautious outlook underlines the challenges that state investment firms like Temasek face as rising protectionist policies and anti-globalization sentiments put their investment and risk management capabilities to test.

  • Reuters2 months ago

    BRIEF-Innovative Pharmaceutical Biotech Posts FY Revenue HK$15.8 MLN

    June 29 (Reuters) - Innovative Pharmaceutical Biotech Ltd : * FY REVENUE HK$15.8 MILLION VERSUS HK$9.2 MILLION * LOSS FOR YEAR ATTRIBUTABLE HK$231.0 MILLION VERSUS LOSS OF HK$169.8 MILLION Source text ...

  • Why Innovative Pharmaceutical Biotech Limited’s (HKG:399) Investor Composition Impacts Your Returns
    Simply Wall St.7 months ago

    Why Innovative Pharmaceutical Biotech Limited’s (HKG:399) Investor Composition Impacts Your Returns

    In this article, I’m going to take a look at Innovative Pharmaceutical Biotech Limited’s (SEHK:399) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subjectRead More...